Adolescents and young adults disproportionately abuse 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'); however, since most MDMA research has concentrated on adults, the effects of MDMA on the developing brain remain obscure. Therefore, we evaluated place conditioning to MDMA (or saline) during late adolescence and assessed anxiety-like behavior and monoamine levels during abstinence. Rats were conditioned to associate 5 or 10 mg/kg MDMA or saline with contextual cues over 4 twice-daily sessions. Five days after conditioning, anxiety-like behavior was examined with the open field test and brain tissue was collected to assess serotonin (5-hydroxytryptamine, 5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the dorsal raphe, amygdala, and hippocampus by high-pressure liquid chromatography (HPLC). In a separate group of rats, anxiety-like and avoidant behaviors were measured using the light-dark box test under similar experimental conditions. MDMA conditioning caused a place aversion at 10, but not at 5, mg/kg, as well as increased anxietylike behavior in the open field and avoidant behavior in light-dark box test at the same dose. Additionally, 10 mg/kg MDMA decreased 5-HT in the dorsal raphe, increased 5-HT and 5-HIAA in the amygdala, and did not alter levels in the hippocampus. Overall, we show that repeated high (10 mg/kg), but not low (5 mg/kg), dose MDMA during late adolescence in rats increases anxiety-like and avoidant behaviors, accompanied by regionspecific alterations in 5-HT levels during abstinence. These results suggest that MDMA causes a region-specific dysregulation of the serotonin system during adolescence that may contribute to maladaptive behavior.
Introduction
3,4-Methylenedioxymethamphetamine (MDMA), also known as 'Ecstasy', is one of the most commonly abused drugs among adolescents and young adults (Johnston et al., 2010) . Specifically, MDMA use is disproportionately greater during late adolescence and young adulthood (i.e. 18 to 25year olds) and declines with age (SAMHSA, 2002) . Although young adults constitute the largest proportion of Ecstasy users, most human studies and the majority of preclinical animal experiments only assess adults. As a result, the effects of MDMA on the developing brain and the subsequent behavioral effects are poorly understood.
The rewarding properties of MDMA are known to differ between adolescent and adult animals. For example, in adult rodents, a range of MDMA doses have positive associative effects demonstrated by a conditioned place preference (Meyer et al., 2002; Robledo et al., 2007; Salzmann et al., 2003) , a behavioral paradigm that associates contextual cues with a drug to assess its rewarding or aversive effects (Bardo and Bevins, 2000) . In adolescent rodents, only a few studies have examined the rewarding effects of MDMA (with place conditioning), and positive associations were only seen at a single, low dose (2.5 mg/kg) in rats (Catlow et al., 2010; Llorente-Berzal et al., 2013) . In mice, MDMA causes place preference at high doses (5-20 mg/kg) in adults and adolescents (Daza-Losada et al., 2007; Ribeiro Do Couto et al., 2011 , 2012 ; however, mice show a differential regulation after MDMA where a dopaminergic mechanism plays a larger role that may account for the place conditioning at high doses (Kindlundh-Hogberg et al., 2007) . Importantly, other doses that produce rewarding effects in adults do not have an effect in younger rats (Catlow et al., 2010; Llorente-Berzal et al., 2013; Meyer et al., 2002; Progress in Neuro-Psychopharmacology & Biological Psychiatry 48 (2014) [229] [230] [231] [232] [233] [234] [235] Abbreviations: MDMA, 3,4-methylenedioxymethamphetamine; HPLC, High Pressure Liquid Chromatography; 5-hydroxytryptamine, 5-HT serotonin; 5-HIAA, 5-hydroxyindoleacetic acid; SERT, serotonin transporter; PND, postnatal date; IP, Intraperitoneal; ANOVA, analysis of variance; SEM, standard error of the mean.
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